Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07109-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Astia Allenzara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Allergy and Immunology and Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC…. Hauptthemen laut MEDLINE: Atherosclerosis, Myositis, Registries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, Dermatology Foundation.
Abstract (Originalsprache)
OBJECTIVE: Idiopathic inflammatory myopathies (IIM) confer an increased risk of morbidity from atherosclerotic cardiovascular disease (ASCVD). While ASCVD risk has been studied in other countries, these results may not be applicable to patients with dermatomyositis (DM) and polymyositis (PM) in the United States. This retrospective analysis of a cohort of patients identified by ICD code from TriNetX investigated the incidence of ASCVD after International Classification of Disease (ICD) codes of DM, PM, dermatopolymyositis (DPM) or juvenile dermatomyositis (JDM). METHOD: Patients were identified by entry of two ICD codes separated by at least 6 months, according to their first diagnosis code; ASCVD was defined as first ICD code for myocardial infarction, ischemic stroke, transient ischemic attack, or peripheral arterial disease. Cox proportional hazards regression modeled time from first IIM ICD code to ASCVD event. RESULTS: A total of 35,554 patients were identified with the mean age at first IIM code of 54 and 26.1% were male. The most common comorbidity for all groups except JDM was hyperlipidemia (39.9%) though 79.2% of patients were on no cholesterol lowering medication. ASCVD occurred in 30.4% of patients with PM, 24.3% of patients with DM and 0.9% of patients with JDM. Patients with PM had a median time to event of 9.7 years (95% Confidence interval (CI) 9.1, 10.7) and 14.3 years (95% CI 12.6, 14.8) for DM. This study demonstrates that ASCVD is a comorbidity occurring after a median of 12.5 years (95% CI 11.9, 13.6) in patients with IIM. CONCLUSIONS: ASCVD appears to be a long-term complication for IIM patients occurring in nearly a quarter of US patients without prior ASCVD with at least two ICD codes for IIM, with a median time to event of 12.5 years. There appears to be a practice gap in the recognition and treatment of hyperlipidemia in these patients. Key Points • Hyperlipidemia was a common comorbidity identified in patients with IIM though most patients were not on cholesterol lowering medication. • Development of ASCVD appears to be a long-term complication for patients with IIM in the United States.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Allergy and Immunology and Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. astia.allenzara@unchealth.unc.edu.
- Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Division of Rheumatology, Allergy and Immunology and Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA.
- Department of Public Health Sciences, Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA.
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- Dermatology Foundation
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Allenzara, A., Jicha, K., Álvarez, C., Nelson, A., & Foulke, G. (2024). Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07109-w
Vancouver
Allenzara A, Jicha K, Álvarez C, Nelson A, Foulke G. Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07109-w
BibTeX
@article{Allenzara2024,
author = {Allenzara, Astia and Jicha, Katherine and Álvarez, Carolina and Nelson, Amanda and Foulke, Galen},
title = {Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07109-w}
}
EUVIMED